Skip to main content
Log in

Pharmacokinetics and quantitative characterization of cefotiam excretion after intravenous administration to patients after cholecystectomy

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Six patients, aged 52 to 71 years, with T-tube drainage of the common bile duct and a urinary catheter after cholecystectomy, were studied in order to evaluate the urinary and biliary excretion and pharmacokinetics of cefotiam in the early postoperative period. Each patient received cefotiam 1 g i.v. as a bolus injection. Cefotiam in plasma, urine, and bile were determined by HPLC. A 2-compartment open model with elimination from the central compartment satisfactorily fitted the plasma levels of the drug. The renal clearance of cefotiam (CLR=133 ml/min) was an order of magnitude greater than its biliary clearance (CLB=11.8 ml/min). Glomerular filtration was the main mechanism for elimination of cefotiam. The values of CLR and CLB in relation to the total plasma clearance (CL=138. ml/min) demonstrated the negligible role of metabolism in elimination of cefotiam in these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Boxenbaum HG, Riegelman S, Elashoff RM (1974) Statistical estimations in pharmacokinetics. J Pharmacokinet Biopharm 2: 123–148

    Google Scholar 

  2. Guyton AC (1981) Textbook of medical physiology, 6th edn. Saunders, Philadelphia London Toronto

    Google Scholar 

  3. Kemmerich B, Lode H, Belmega G, Jendroschek T, Borner K, Koeppe P (1983) Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam. Antimicrob Agents Chemother 23: 429–434

    Google Scholar 

  4. Meijer DKF, Weitering JG, Vermeer GA, Scaf AHJ (1979) Comparative pharmacokinetics of d-tubocurarine and metocurine in man. Anesthesiology 51: 402–407

    Google Scholar 

  5. Meijer DKF, Weitering JG, Vermeer GA (1983) Pharmacokinetics of biliary excretion in man V dibromosulfophthalein. Eur J Clin Pharmacol 24: 549–556

    Google Scholar 

  6. Riegelman S, Loo JCK, Rowland M (1968) Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment. J Pharm Sci 57: 117–123

    Google Scholar 

  7. Rouan MC, Abadie F, Leclerc A, Juge F (1983) Systemic approach to the determination of cephalosporins in biological fluids by reversed-phase liquid chromatography. J Chromatogr 275: 133–144

    Google Scholar 

  8. Tanayama S, Kondo T, Kanai Y (1978) Metabolic fate of SCE-963, a new broad-spectrum cephalosporin, after parenteral administration in rats and dogs. J Antibiotics 31: 703–711

    Google Scholar 

  9. Wagner JG (1975) Fundamentals of clinical pharmacokinetics, 2nd edn. Drug Intelligence Publications, Hamilton, Illinois

    Google Scholar 

  10. Yamamoto T, Kuwahara I, Adachi Y, Yamaguchi N (1979) Clinical phase I studies on cefotiam (SCE-953). Chemotherapy 27 (S-3): 172–195

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Terziivanov, D., Gerova, Z., Vlahov, V. et al. Pharmacokinetics and quantitative characterization of cefotiam excretion after intravenous administration to patients after cholecystectomy. Eur J Clin Pharmacol 30, 439–444 (1986). https://doi.org/10.1007/BF00607957

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00607957

Key words

Navigation